Assetmark Inc. Invests $52,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Assetmark Inc. acquired a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 611 shares of the company’s stock, valued at approximately $52,000. Other institutional investors have also recently bought and sold […]
Assetmark Inc. acquired a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 611 shares of the company’s stock, valued at approximately $52,000. Other institutional investors have also recently bought and sold […]
